Testing Bundle Lowered Maternal Screening Costs by 46%
Healthcare providers in high-volume markets can now procure essential prenatal test kits at a 22% to 46% discount.
Updated on Sept. 29, 2026 in Healthcare

Live Poll
Do you support prioritizing lower-cost bundled testing programs to expand national health screening coverage?
Premier Medical Corporation and Impact Nexus Africa have launched a $1 testing bundle for HIV, syphilis, and hepatitis B to improve prenatal screening. The offering is designed to streamline diagnostics by combining three tests into a single unit, with a minimum order requirement of 100,000 bundles.
Why it matters
The initiative addresses significant gaps in maternal health diagnostics by lowering the price barrier for facilities in targeted nations. This cost reduction supports global efforts to eliminate mother-to-child transmission of these infections by scaling access to screening services.
The $1 bundle represents a 22 to 46 percent discount compared to procuring individual tests, with $215 million in total commodity savings projected through 2035. The rollout targets a market where screening rates are low, such as Nigeria, where only 12.3 percent of mothers receive testing.
The players
Premier Medical Corporation
A developer and manufacturer of rapid diagnostic testing kits and medical screening commodities.
Impact Nexus Africa
A strategic partner focused on deploying healthcare diagnostics and service delivery models across African markets.
The details
The bundle aggregates an HIV/syphilis combo test with a hepatitis B surface antigen test, requiring no change to existing antenatal care infrastructure. Beyond the physical kits, the $1 price point includes digital competency tools and assessment services. Operators must commit to a minimum order quantity of 100,000 units to participate in this pricing structure.
Timeline
2025: Federal Ministry of Health planned free hepatitis B testing.
2026: Analysis of Nigeria Demographic and Health Survey data.
2026-2035: Period for projected savings and infant infection reduction.
Market Landscape
The initiative aligns with global efforts to eliminate mother-to-child transmission of HIV, syphilis, and hepatitis B. It follows a pattern of private sector commercial initiatives designed to meet these international health benchmarks through bundled procurement models.
Healthcare facility managers should evaluate their current procurement contracts against the 100,000-unit threshold to determine if bundling is viable. Factor in that the $1 base price excludes local logistics and regulatory expenses, which may fluctuate significantly by region.
The takeaway
The move demonstrates that bundling diagnostics can significantly lower unit costs while utilizing existing infrastructure for rapid implementation. Managers should monitor the 2026-2035 progress metrics to assess if this model effectively scales in their specific operating regions.
Further reading
For more on evolving diagnostic standards, see our Healthcare section.
Live Poll
Do you support prioritizing lower-cost bundled testing programs to expand national health screening coverage?






